Nov 11, 2022 / 04:30PM GMT
Grace Kim -
Hello, and welcome to Molecular Templates R&D Day 2022. My name is Grace Kim, Head of Investor Relations. And before we start, I'd like to remind you that today, we'll be making some forward-looking statements, which reflect our current views and expectations around both the potential attributes of our engineered toxin body technology and around our product candidates. We caution existing and prospective investors not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. For more information, please refer to our filings with the Securities and Exchange Commission. (Operator Instructions)
And at this time, it's my great pleasure to turn the program over to CEO, Eric Poma; and CMO, Roger Waltzman. Gentlemen?
Eric E. Poma - Molecular Templates, Inc. - CEO, Chief Scientific Officer & Director
Thanks, Grace. Thanks, everyone, coming both in person and online. We're going to spend the next hour or so really talking about the clinical data we're seeing. We're really excited about the early clinical
Molecular Templates Inc To Present Interim Data and Host R&D Day at The Society for Immunotherapy of Cancer's (SITC) 37th Annual Meeting Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers